Evidence map›Paper›PMID 35480694›Full record

ArticleRSC advances2021

Design, synthesis, biological assessment and

Mohamed A S Badawy, Eman K A Abdelall, El-Shaymaa El-Nahass, Khaled R A Abdellatif, Hamdy M Abdel-Rahman

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamed A S BadawyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Nahda University (NUB) Beni-Suef 62513 Egypt Mohamed.aboalhassan@nub.edu.eg +2001066394559.ORCID https://orcid.org/0000-0002-0145-7868
Eman K A AbdelallDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University Beni-Suef 62514 Egypt.ORCID https://orcid.org/0000-0001-6075-3563
El-Shaymaa El-NahassDepartment of Pathology, Faculty of Veterinary Medicine, Beni-Suef University Beni-Suef 62511 Egypt.ORCID https://orcid.org/0000-0003-2072-6290
Khaled R A AbdellatifDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University Beni-Suef 62514 Egypt.ORCID https://orcid.org/0000-0002-5815-9677
Hamdy M Abdel-RahmanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Nahda University (NUB) Beni-Suef 62513 Egypt Mohamed.aboalhassan@nub.edu.eg +2001066394559.ORCID https://orcid.org/0000-0003-1355-8380

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel series of benzimidazole derivatives wherein 4-(methylsulfonyl) phenyl pharmacophore attached

Identifiers

PMID35480694
PMCPMC9037807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.